Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
national top stories
4
×
boston
clinical trials
fda
new york blog main
new york top stories
pfizer
rna interference
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
akcea therapeutics
alnylam pharmaceuticals
arrowhead pharmaceuticals
biotech
deals
eli lilly
hereditary transthyretin amyloidosis
indiana blog main
indiana top stories
inotersen
nobel prize
onpattro
patisiran
tafamidis
wisconsin blog main
wisconsin top stories
a2 biotherapeutics
aduro biotech
agency
akili interactive labs
alexion pharmaceuticals
alicia hager
alnylam pharmaceutials
alpha-1 antitrypsin
What
rnai
4
×
alnylam
drug
fda
gets
interference
medicine
rna
abandoning
afternoon
ago
alliance
alnylam’s
approved
approves
baggage
bio
bristol
buy
calls
cells
changing
color
companies
crispr
cuts
days
deal
development
dicerna
ema
employ
europe
follows
free
gene
growing
harmful
history
hits
Language
unset
Current search:
rnai
×
" national top stories "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug